Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Market Overview
1.1 Opioids Drug Product Scope
1.2 Opioids Drug by Type
1.2.1 Global Opioids Drug Sales by Type (2020 & 2024 & 2031)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Opioids Drug by Application
1.3.1 Global Opioids Drug Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Global Opioids Drug Market Estimates and Forecasts (2020-2031)
1.4.1 Global Opioids Drug Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Opioids Drug Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Opioids Drug Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Opioids Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Opioids Drug Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Opioids Drug Sales Market Share by Region (2020-2025)
2.2.2 Global Opioids Drug Revenue Market Share by Region (2020-2025)
2.3 Global Opioids Drug Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Opioids Drug Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Opioids Drug Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Opioids Drug Market Size and Prospective (2020-2031)
2.4.2 Europe Opioids Drug Market Size and Prospective (2020-2031)
2.4.3 Israel Opioids Drug Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Opioids Drug Historic Market Review by Type (2020-2025)
3.1.1 Global Opioids Drug Sales by Type (2020-2025)
3.1.2 Global Opioids Drug Revenue by Type (2020-2025)
3.1.3 Global Opioids Drug Price by Type (2020-2025)
3.2 Global Opioids Drug Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Opioids Drug Sales Forecast by Type (2026-2031)
3.2.2 Global Opioids Drug Revenue Forecast by Type (2026-2031)
3.2.3 Global Opioids Drug Price Forecast by Type (2026-2031)
3.3 Different Types Opioids Drug Representative Players
4 Global Market Size by Application
4.1 Global Opioids Drug Historic Market Review by Application (2020-2025)
4.1.1 Global Opioids Drug Sales by Application (2020-2025)
4.1.2 Global Opioids Drug Revenue by Application (2020-2025)
4.1.3 Global Opioids Drug Price by Application (2020-2025)
4.2 Global Opioids Drug Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Opioids Drug Sales Forecast by Application (2026-2031)
4.2.2 Global Opioids Drug Revenue Forecast by Application (2026-2031)
4.2.3 Global Opioids Drug Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Opioids Drug Application
5 Competition Landscape by Players
5.1 Global Opioids Drug Sales by Players (2020-2025)
5.2 Global Top Opioids Drug Players by Revenue (2020-2025)
5.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Drug as of 2024)
5.4 Global Opioids Drug Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Opioids Drug, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Opioids Drug, Product Type & Application
5.7 Global Key Manufacturers of Opioids Drug, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Opioids Drug Sales by Company
6.1.1.1 North America Opioids Drug Sales by Company (2020-2025)
6.1.1.2 North America Opioids Drug Revenue by Company (2020-2025)
6.1.2 North America Opioids Drug Sales Breakdown by Type (2020-2025)
6.1.3 North America Opioids Drug Sales Breakdown by Application (2020-2025)
6.1.4 North America Opioids Drug Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Opioids Drug Sales by Company
6.2.1.1 Europe Opioids Drug Sales by Company (2020-2025)
6.2.1.2 Europe Opioids Drug Revenue by Company (2020-2025)
6.2.2 Europe Opioids Drug Sales Breakdown by Type (2020-2025)
6.2.3 Europe Opioids Drug Sales Breakdown by Application (2020-2025)
6.2.4 Europe Opioids Drug Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 Israel Market: Players, Segments, Downstream and Major Customers
6.3.1 Israel Opioids Drug Sales by Company
6.3.1.1 Israel Opioids Drug Sales by Company (2020-2025)
6.3.1.2 Israel Opioids Drug Revenue by Company (2020-2025)
6.3.2 Israel Opioids Drug Sales Breakdown by Type (2020-2025)
6.3.3 Israel Opioids Drug Sales Breakdown by Application (2020-2025)
6.3.4 Israel Opioids Drug Major Customer
6.3.5 Israel Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Teva
7.1.1 Teva Company Information
7.1.2 Teva Business Overview
7.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Teva Opioids Drug Products Offered
7.1.5 Teva Recent Development
7.2 Purdue Pharma
7.2.1 Purdue Pharma Company Information
7.2.2 Purdue Pharma Business Overview
7.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Purdue Pharma Opioids Drug Products Offered
7.2.5 Purdue Pharma Recent Development
7.3 Mallinckrodt
7.3.1 Mallinckrodt Company Information
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Mallinckrodt Opioids Drug Products Offered
7.3.5 Mallinckrodt Recent Development
7.4 Amneal Pharma
7.4.1 Amneal Pharma Company Information
7.4.2 Amneal Pharma Business Overview
7.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Amneal Pharma Opioids Drug Products Offered
7.4.5 Amneal Pharma Recent Development
7.5 Collegium
7.5.1 Collegium Company Information
7.5.2 Collegium Business Overview
7.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Collegium Opioids Drug Products Offered
7.5.5 Collegium Recent Development
7.6 J&J
7.6.1 J&J Company Information
7.6.2 J&J Business Overview
7.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.6.4 J&J Opioids Drug Products Offered
7.6.5 J&J Recent Development
7.7 Endo
7.7.1 Endo Company Information
7.7.2 Endo Business Overview
7.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Endo Opioids Drug Products Offered
7.7.5 Endo Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Pfizer Opioids Drug Products Offered
7.8.5 Pfizer Recent Development
7.9 INSYS
7.9.1 INSYS Company Information
7.9.2 INSYS Business Overview
7.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.9.4 INSYS Opioids Drug Products Offered
7.9.5 INSYS Recent Development
7.10 Mylan
7.10.1 Mylan Company Information
7.10.2 Mylan Business Overview
7.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Mylan Opioids Drug Products Offered
7.10.5 Mylan Recent Development
7.11 Hikma
7.11.1 Hikma Company Information
7.11.2 Hikma Business Overview
7.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Hikma Opioids Drug Products Offered
7.11.5 Hikma Recent Development
7.12 Egalet
7.12.1 Egalet Company Information
7.12.2 Egalet Business Overview
7.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Egalet Opioids Drug Products Offered
7.12.5 Egalet Recent Development
8 Opioids Drug Manufacturing Cost Analysis
8.1 Opioids Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Opioids Drug
8.4 Opioids Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Opioids Drug Distributors List
9.3 Opioids Drug Customers
10 Opioids Drug Market Dynamics
10.1 Opioids Drug Industry Trends
10.2 Opioids Drug Market Drivers
10.3 Opioids Drug Market Challenges
10.4 Opioids Drug Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

List of Tables
Table 1. Global Opioids Drug Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Opioids Drug Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Opioids Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Opioids Drug Sales (M Units) by Region (2020-2025)
Table 5. Global Opioids Drug Sales Market Share by Region (2020-2025)
Table 6. Global Opioids Drug Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Opioids Drug Revenue Share by Region (2020-2025)
Table 8. Global Opioids Drug Sales (M Units) Forecast by Region (2026-2031)
Table 9. Global Opioids Drug Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Opioids Drug Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Opioids Drug Revenue Share Forecast by Region (2026-2031)
Table 12. Global Opioids Drug Sales by Type (M Units) & (2020-2025)
Table 13. Global Opioids Drug Sales Share by Type (2020-2025)
Table 14. Global Opioids Drug Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Opioids Drug Price by Type (USD/Unit) & (2020-2025)
Table 16. Global Opioids Drug Sales by Type (M Units) & (2026-2031)
Table 17. Global Opioids Drug Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Opioids Drug Price by Type (USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Opioids Drug Sales by Application (M Units) & (2020-2025)
Table 21. Global Opioids Drug Sales Share by Application (2020-2025)
Table 22. Global Opioids Drug Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Opioids Drug Price by Application (USD/Unit) & (2020-2025)
Table 24. Global Opioids Drug Sales by Application (M Units) & (2026-2031)
Table 25. Global Opioids Drug Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Opioids Drug Price by Application (USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in Opioids Drug Application
Table 28. Global Opioids Drug Sales by Company (M Units) & (2020-2025)
Table 29. Global Opioids Drug Sales Share by Company (2020-2025)
Table 30. Global Opioids Drug Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Opioids Drug Revenue Share by Company (2020-2025)
Table 32. Global Opioids Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Drug as of 2024)
Table 33. Global Market Opioids Drug Average Price by Company (USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Opioids Drug, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Opioids Drug, Product Type & Application
Table 36. Global Key Manufacturers of Opioids Drug, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Opioids Drug Sales by Company (2020-2025) & (M Units)
Table 39. North America Opioids Drug Sales Market Share by Company (2020-2025)
Table 40. North America Opioids Drug Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Opioids Drug Revenue Market Share by Company (2020-2025)
Table 42. North America Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 43. North America Opioids Drug Sales Market Share by Type (2020-2025)
Table 44. North America Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 45. North America Opioids Drug Sales Market Share by Application (2020-2025)
Table 46. Europe Opioids Drug Sales by Company (2020-2025) & (M Units)
Table 47. Europe Opioids Drug Sales Market Share by Company (2020-2025)
Table 48. Europe Opioids Drug Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Opioids Drug Revenue Market Share by Company (2020-2025)
Table 50. Europe Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 51. Europe Opioids Drug Sales Market Share by Type (2020-2025)
Table 52. Europe Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 53. Europe Opioids Drug Sales Market Share by Application (2020-2025)
Table 54. Israel Opioids Drug Sales by Company (2020-2025) & (M Units)
Table 55. Israel Opioids Drug Sales Market Share by Company (2020-2025)
Table 56. Israel Opioids Drug Revenue by Company (2020-2025) & (US$ Million)
Table 57. Israel Opioids Drug Revenue Market Share by Company (2020-2025)
Table 58. Israel Opioids Drug Sales by Type (2020-2025) & (M Units)
Table 59. Israel Opioids Drug Sales Market Share by Type (2020-2025)
Table 60. Israel Opioids Drug Sales by Application (2020-2025) & (M Units)
Table 61. Israel Opioids Drug Sales Market Share by Application (2020-2025)
Table 62. Teva Company Information
Table 63. Teva Description and Business Overview
Table 64. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Teva Opioids Drug Product
Table 66. Teva Recent Development
Table 67. Purdue Pharma Company Information
Table 68. Purdue Pharma Description and Business Overview
Table 69. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Purdue Pharma Opioids Drug Product
Table 71. Purdue Pharma Recent Development
Table 72. Mallinckrodt Company Information
Table 73. Mallinckrodt Description and Business Overview
Table 74. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Mallinckrodt Opioids Drug Product
Table 76. Mallinckrodt Recent Development
Table 77. Amneal Pharma Company Information
Table 78. Amneal Pharma Description and Business Overview
Table 79. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Amneal Pharma Opioids Drug Product
Table 81. Amneal Pharma Recent Development
Table 82. Collegium Company Information
Table 83. Collegium Description and Business Overview
Table 84. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Collegium Opioids Drug Product
Table 86. Collegium Recent Development
Table 87. J&J Company Information
Table 88. J&J Description and Business Overview
Table 89. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. J&J Opioids Drug Product
Table 91. J&J Recent Development
Table 92. Endo Company Information
Table 93. Endo Description and Business Overview
Table 94. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Endo Opioids Drug Product
Table 96. Endo Recent Development
Table 97. Pfizer Company Information
Table 98. Pfizer Description and Business Overview
Table 99. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Pfizer Opioids Drug Product
Table 101. Pfizer Recent Development
Table 102. INSYS Company Information
Table 103. INSYS Description and Business Overview
Table 104. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. INSYS Opioids Drug Product
Table 106. INSYS Recent Development
Table 107. Mylan Company Information
Table 108. Mylan Description and Business Overview
Table 109. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Mylan Opioids Drug Product
Table 111. Mylan Recent Development
Table 112. Hikma Company Information
Table 113. Hikma Description and Business Overview
Table 114. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Hikma Opioids Drug Product
Table 116. Hikma Recent Development
Table 117. Egalet Company Information
Table 118. Egalet Description and Business Overview
Table 119. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Egalet Opioids Drug Product
Table 121. Egalet Recent Development
Table 122. Production Base and Market Concentration Rate of Raw Material
Table 123. Key Suppliers of Raw Materials
Table 124. Opioids Drug Distributors List
Table 125. Opioids Drug Customers List
Table 126. Opioids Drug Market Trends
Table 127. Opioids Drug Market Drivers
Table 128. Opioids Drug Market Challenges
Table 129. Opioids Drug Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources


List of Figures
Figure 1. Opioids Drug Product Picture
Figure 2. Global Opioids Drug Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Opioids Drug Sales Market Share by Type in 2024 & 2031
Figure 4. Oxycodone Product Picture
Figure 5. Hydromorphone Product Picture
Figure 6. Codeine Product Picture
Figure 7. Fentanyl Product Picture
Figure 8. Global Opioids Drug Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Opioids Drug Sales Market Share by Application in 2024 & 2031
Figure 10. Pain Relief Examples
Figure 11. Anesthesia Examples
Figure 12. Others Examples
Figure 13. Global Opioids Drug Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Opioids Drug Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Opioids Drug Sales (M Units) Growth Rate (2020-2031)
Figure 16. Global Opioids Drug Price Trends Growth Rate (2020-2031) & (USD/Unit)
Figure 17. Opioids Drug Report Years Considered
Figure 18. Global Market Opioids Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Opioids Drug Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Opioids Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Opioids Drug Sales (M Units) Growth Rate (2020-2031)
Figure 22. Europe Opioids Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Opioids Drug Sales (M Units) Growth Rate (2020-2031)
Figure 24. Israel Opioids Drug Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Israel Opioids Drug Sales (M Units) Growth Rate (2020-2031)
Figure 26. Global Opioids Drug Revenue Share by Type (2020-2025)
Figure 27. Global Opioids Drug Sales Share by Type (2026-2031)
Figure 28. Global Opioids Drug Revenue Share by Type (2026-2031)
Figure 29. Global Opioids Drug Revenue Share by Application (2020-2025)
Figure 30. Global Opioids Drug Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Opioids Drug Sales Share by Application (2026-2031)
Figure 32. Global Opioids Drug Revenue Share by Application (2026-2031)
Figure 33. Global Opioids Drug Sales Share by Company (2024)
Figure 34. Global Opioids Drug Revenue Share by Company (2024)
Figure 35. Global 5 Largest Opioids Drug Players Market Share by Revenue in Opioids Drug: 2020 & 2024
Figure 36. Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Opioids Drug
Figure 38. Manufacturing Process Analysis of Opioids Drug
Figure 39. Opioids Drug Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed